clofarabine has been researched along with moxifloxacin in 2 studies
| Studies (clofarabine) | Trials (clofarabine) | Recent Studies (post-2010) (clofarabine) | Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) |
|---|---|---|---|---|---|
| 424 | 101 | 280 | 3,157 | 552 | 1,690 |
| Protein | Taxonomy | clofarabine (IC50) | moxifloxacin (IC50) |
|---|---|---|---|
| DNA gyrase subunit B | Staphylococcus aureus | 5.1033 | |
| DNA gyrase subunit A | Escherichia coli K-12 | 1.4 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 1.4 | |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | 0.8 | |
| DNA gyrase subunit A | Staphylococcus aureus | 7.25 | |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 8.525 | |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 8.66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for clofarabine and moxifloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for clofarabine and moxifloxacin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |